Hodges Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$4.44M | – | 247 |
|
|
2021
Q2 | $4.44M | Sell |
20,000
-5,000
| -20% | -$1.11M | 0.5% | 71 |
|
|
2021
Q1 | $3.31M | Buy |
25,000
+4,500
| +22% | +$595K | 0.46% | 78 |
|
|
2020
Q4 | $3.55M | Sell |
20,500
-15,250
| -43% | -$2.64M | 0.56% | 63 |
|
|
2020
Q3 | $3.98M | Buy |
+35,750
| New | +$3.98M | 0.77% | 42 |
|
|
2019
Q1 | – | Sell |
-75,500
| Closed | -$2.53M | – | 242 |
|
|
2018
Q4 | $2.53M | Sell |
75,500
-66,250
| -47% | -$2.22M | 0.28% | 82 |
|
|
2018
Q3 | $7.43M | Sell |
141,750
-88,250
| -38% | -$4.62M | 0.55% | 52 |
|
|
2018
Q2 | $7.2M | Sell |
230,000
-55,500
| -19% | -$1.74M | 0.53% | 61 |
|
|
2018
Q1 | $6.22M | Buy |
285,500
+12,000
| +4% | +$262K | 0.49% | 58 |
|
|
2017
Q4 | $5.53M | Buy |
273,500
+63,000
| +30% | +$1.27M | 0.41% | 72 |
|
|
2017
Q3 | $4.18M | Buy |
+210,500
| New | +$4.18M | 0.28% | 85 |
|